Christopher Bolten
6 June 2024NewsCareersMarisa Woutersen

Greenberg Traurig adds medtech expert as shareholder

Latest addition to the firm brings medtech expertise and experience assisting digital health companies using AI and machine learning | Move comes at a time when “health care companies are thinking more like technology companies”.

Greenberg Traurig has added Christopher Bolten as a shareholder to its life sciences and medical technology practice in the firm’s San Diego office.

Bolten makes the move from being partner and deputy practice group leader of IP at Eversheds Sutherland.

He began his career as a mechanical engineer and now specialises in medical technology.

His expertise is in assisting medical device and digital health companies across the US, Europe, and Israel in building and protecting their patent portfolios.

Additionally, Bolten conducts IP due diligence for venture capital firms, advising on the risks associated with their medtech investments.

Michelle Ferreira, senior vice president and co-managing shareholder of Greenberg Traurig’s San Francisco and Silicon Valley offices, said “healthcare companies are now thinking more like technology companies”, therefore Bolten’s area of practice is “an essential addition” to the firm's IP and patents and innovation strategies practices.

“He has a broad cross-border practice that runs the gamut from startups seeking FDA approval for single devices to well-established multinational public companies; in other words, Chris’s clients could benefit from Greenberg Traurig’s vast global platform,” she added.

Bolten’s experience with digital health companies using artificial intelligence and machine learning dates back to before these technologies became mainstream.

His work includes collaborating with companies that use AI to enhance surgical robots and analyse heart signals for diagnosing cardiac abnormalities, such as atrial fibrillation—a feature now available in FDA-approved consumer smartwatches.

Bolten’s work in AI and digital health has been aimed at improving patient care.

David Gay, shareholder at Greenberg Traurig, said: “I worked with Chris when he was a junior attorney, and it’s been a joy to see his rise here in Southern California, where he is well-known in the tech and legal spaces.”

According to Gay, Bolten will “perfectly complement” the existing life sciences practice Greenberg Traurig has developed.

Bolten’s experience in wireless communication and cellular technology has merged with his work in digital health, as more companies develop software and data tools to offer precise diagnoses and treatments, often using AI.

Commenting on his move, Bolten said: “Greenberg Traurig’s footprint and global platform overlap neatly with where my clients are based.

“The firm has a stellar reputation in the IP and patent prosecution community, and I could not be more excited to join a first-class group of attorneys,” he added.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
20 July 2018   Greenberg Traurig announced on Monday, July 16, that it has added Brian Rubenstein as a shareholder in its Philadelphia office.
article
11 July 2013   US law firm Greenberg Traurig has appointed shareholder Jennifer Camacho as co-chair of its Boston IP group.

More on this story

Americas
20 July 2018   Greenberg Traurig announced on Monday, July 16, that it has added Brian Rubenstein as a shareholder in its Philadelphia office.
article
11 July 2013   US law firm Greenberg Traurig has appointed shareholder Jennifer Camacho as co-chair of its Boston IP group.

More on this story

Americas
20 July 2018   Greenberg Traurig announced on Monday, July 16, that it has added Brian Rubenstein as a shareholder in its Philadelphia office.
article
11 July 2013   US law firm Greenberg Traurig has appointed shareholder Jennifer Camacho as co-chair of its Boston IP group.